American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has strengthened its commercial leadership with the appointment of Alec Rossa as Chief Revenue Officer, a move that reflects the company’s increasing focus on preparing its fusion technology platform for future commercialization alongside ongoing engineering and testing activities. The announcement, made on July 22, […]

Cartilage Regeneration Gains Strategic Validation The orthopedic industry is increasingly focused on technologies that can address cartilage damage by promoting tissue regeneration rather than simply managing symptoms. This opportunity gained additional validation when Smith+Nephew completed its acquisition of CartiHeal, a developer of cartilage repair technology, in a transaction valued at up to $330 million. The […]

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Few technologies have reshaped modern warfare as dramatically as unmanned aerial systems (“drones”). They provide real-time battlefield intelligence, logistical support and precision capabilities while keeping personnel farther from danger. Compared with many traditional military platforms, drones also offer a […]

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. For Bougainville, the path to independence is about more than politics. It is also about economics. As the autonomous Pacific region continues discussions regarding its future political status, the development of its vast mineral resources has emerged as one of the most […]

Earth Science Tech (OTC: ETST), a diversified holding company, is building a healthcare platform that vertically integrates various aspects of patient care, from consultation to fulfillment. The company achieves this through the synergy of its specialized subsidiaries RxCompoundStore (“RxCS”), Mister Meds, and Peaks Curative LLC. RxCS is a Miami-based licensed compounding pharmacy that provides sterile […]

A Widening Market for Response-to-Resistance Technology High-profile use-of-force incidents have driven costly litigation, strained community trust, and increased scrutiny of how officers are equipped and trained. That environment has pushed agencies toward tools that create time, distance, and tactical advantage, particularly in encounters involving individuals in mental- or behavioral-health crises and has widened the customer […]

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. Rare earth elements (“REEs”) have quietly become one of the most consequential material groups in the modern economy, powering everything from electric vehicle motors to fighter jet guidance systems. Their unique magnetic and conductive properties make them nearly […]

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Cancer drug development has three persistent problems. Tumors evolve resistance to therapies that once worked. Clinical trials fail often and cost enormously, frequently because the right patients are hard to identify. And many promising drugs never reach patients because they are too […]

Palladium is one of the most strategically important metals on earth, and the supply chain that delivers it to Western manufacturers has never been more exposed. Into that gap steps Greenland Mines (NASDAQ: GRML), which just reported a 31% increase in its indicated palladium equivalent resource at its Skaergaard project in southeast Greenland, one of the largest undeveloped […]

Regentis Biomaterials (NYSE American: RGNT) is developing regenerative biomaterial technology as healthcare shifts toward therapies designed to restore damaged tissue rather than simply manage symptoms. With cartilage defects affecting hundreds of thousands of patients each year and contributing to pain, reduced mobility, and degenerative joint disease, the company is targeting one of orthopedic medicine’s largest […]